The latest research study by IMARC Group, “Contrast Media Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” offers a comprehensive analysis of the industry, which comprises insights on global contrast media market share. The market size reached US$ 4.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.8 Billion by 2028, exhibiting a growth rate (CAGR) of 4.11% during 2023-2028.
Contrast media represents substances that are utilized to improve the contrast of the structures of fluids in the body during the process of medical imaging. They are available in numerous product variants, including iodinated, barium-based, gadolinium-based microbubble, etc. These contrast media materials enhance the visibility of targeted issues and the structure of blood vessels. They even absorb or alter ultrasound or electromagnetism, which emits radiation themselves. Consequently, contrast media products find extensive applications in hospitals and clinics across countries.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/contrast-media-market/requestsample
Contrast Media Market Trends and Drivers:
The expanding geriatric population and the increasing prevalence of various chronic ailments, such as cancer, cardiovascular diseases, and neurological disorders, are primarily driving the contrast media market. Besides this, the inflating investments in research and development (R&D) projects and the growing merger and acquisition activities among leading market players to innovate new products are further stimulating the market growth. In addition to this, the shifting preferences toward image-directed diagnostics procedures for effective results and the elevating technological advancements in medical imaging are acting as significant growth-inducing factors. Apart from this, the launch of favorable policies by government bodies, especially in developing countries, to enhance the healthcare infrastructure and the escalating number of angioplasty procedures that require iodinated contrast media are also positively influencing the global market. Furthermore, the emerging trend of minimally invasive surgeries (MID) among patients and medical professionals, on account of several advantages, including faster recovery time, lower stress on the immune system, reduced stress on the immune system, shortened hospital stays, etc., and the rising patent expiry of multiple branded products are expected to stimulate the contrast media market over the forecasted period.
Market 2023-2028 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Bayer AG, Beijing Beilu Pharmaceuticals Company Limited, Bracco S.p.A., General Electric Company, Guerbet, iMAX Diagnostic Imaging Limited, J.B. Chemicals & Pharmaceuticals Limited, Jodas Expoim Pvt. Ltd., Lantheus, Nano Therapeutics Pvt Ltd, SANOCHEMIA Pharmazeutika GmbH, TAEJOON PHARM Co. Ltd. and Trivitron Healthcare.
The report has segmented the market on the basis of type, modality, application, route of administration and end user.
Breakup by Type:
- Iodinated Contrast Media
- Gadolinium-based Contrast Media
- Microbubble Contrast Media
- Barium-based Contrast Media
Breakup by Modality:
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
Breakup by Application:
- Interventional Radiology
- Interventional Cardiology
Breakup by Route of Administration:
- Oral Route
- Rectal Route
Breakup by End User:
- Hospital, Clinics and Ambulatory Surgery Centers
- Diagnostic Imaging Centers
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
|Base Year of the Analysis||2022|
|Segment Coverage||Type, Modality, Application, Route of Administration, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Bayer AG, Beijing Beilu Pharmaceuticals Company Limited, Bracco S.p.A., General Electric Company, Guerbet, iMAX Diagnostic Imaging Limited, J.B. Chemicals & Pharmaceuticals Limited, Jodas Expoim Pvt. Ltd., Lantheus, Nano Therapeutics Pvt Ltd, SANOCHEMIA Pharmazeutika GmbH, TAEJOON PHARM Co. Ltd. and Trivitron Healthcare|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499|
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.